| Primary information |
|---|
| CancerPPD ID | 1425 |
| PMID | 7768152, 21403917 |
| YEAR | 1994 |
| SEQUENCE | GIGKFLKKAKKFGKAFVKILKK |
| LENGTH | 22 |
| NAME | PexigaNAn MSI-78 |
| C-ter Modification | Amidation |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | L |
| Non-Natural | None |
| NATURE | Antimicrobial |
| ACTIVITY | 75% Cytotoxicity at 0.5 µg/ml |
| SOURCE | Helical peptide with a predominance of one or more amino acids tryptophane-rich |
| Cancer Type | Lymphoma Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Blood |
| CELL LINE | U-937 |
| TEST TIME | 6-h |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | CHHHHHHHHTTTHHHHTTTCCC |
| SMILES | NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| 2lsaA | NA | NA | NA | NA | NA | NA | NA |
|